Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.54 |
| ▸ | FDPS | P14324 | 4/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | THRB | P10828 | 1/20 | 0.42 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.42 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.40 |
| ▸ | GPR84 | Q9NQS5 | 3/20 | 0.38 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.38 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7957865 | 0.87 | LMNA (0.52) | LMNAFDPSTSHRTHRBDNM1 | |
| SCHEMBL20746363 | 0.86 | LMNA (0.68) | LMNAFDPSTSHRTHRBDNM1 | |
| SCHEMBL20740310 | 0.86 | LMNA (0.68) | LMNAFDPSTSHRTHRBDNM1 | |
| SCHEMBL20746348 | 0.86 | LMNA (0.68) | LMNAFDPSTSHRTHRBDNM1 | |
| SCHEMBL20746409 | 0.86 | LMNA (0.68) | LMNAFDPSTSHRTHRBDNM1 | |
| SCHEMBL25125871 | 0.86 | LMNA (0.68) | LMNAFDPSTSHRTHRBDNM1 | |
| SCHEMBL20746400 | 0.86 | LMNA (0.68) | LMNAFDPSTSHRTHRBDNM1 | |
| SCHEMBL21996120 | 0.86 | LMNA (0.68) | LMNAFDPSTSHRTHRBDNM1 | |
| SCHEMBL20746187 | 0.86 | LMNA (0.68) | LMNAFDPSTSHRTHRBDNM1 | |
| SCHEMBL20746351 | 0.86 | LMNA (0.68) | LMNAFDPSTSHRTHRBDNM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8106200-B2 | Pyridine borane complexes | BASF SE (DE) | 2012-01-31 | — | — | US | disclosed |
| US-20110207934-A1 | PYRIDINE BORANE COMPLEXES | BASF SE (DE) | 2011-08-25 | — | — | US | disclosed |
| EP-2066631-B1 | PYRIDINE BORANE COMPLEXES | BASF SE (DE) | 2011-04-06 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110207934-A1 | PYRIDINE BORANE COMPLEXES | NBAS, BRD8, PAXBP1 | LMNA 3308/4885FDPS 121/4885TSHR 3483/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.